Case report: Rare presentation of double primary malignancies of the lung and thyroid: a difficult diagnosis

被引:0
作者
Chen, Shun-Ping [1 ]
Li, Peng [2 ]
Pan, Yi-Fei [3 ]
Jiang, Xin [1 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 1, Dept Ultrasonog, Wenzhou, Peoples R China
[2] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pathol, Wenzhou, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 1, Dept Colorectal & Anal Surg, Wenzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2024年 / 13卷
关键词
double cancer; multiple primary cancers; MPCs; papillary thyroid carcinoma; PTC; lung adenocarcinoma; BRAFV600E; ALK; CANCER; MICROCARCINOMA;
D O I
10.3389/fonc.2023.1251492
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This report describes a rare case of double primary cancer in a female patient aged 49 years who died 2 years after diagnosis. The patient was diagnosed with BRAFV600E-mutant metastatic papillary thyroid carcinoma (PTC) and ALK fusion-positive metastatic lung adenocarcinoma. She presented with multifocal thyroid lesions and underwent radical thyroidectomy and bilateral cervical lymphadenectomy. Thyroid ultrasound revealed the presence of five hypoechoic nodules with irregular margins and microcalcifications; an irregular inhomogeneous hypoechoic level IV cervical lymph node was also found on the right side. Histological analysis confirmed the presence of metastatic PTC, and the tumor tested positive for the BRAFV600E mutation. Ultrasound of the neck, which was performed 4 months postdischarge, revealed enlargement of the left-sided cervical lymph nodes; a biopsy from these nodes confirmed a diagnosis of metastatic PTC. Positron emission tomography-computed tomography scans revealed the presence of multiple pulmonary hypermetabolic foci scattered across bilateral lung fields. Multiple hypermetabolic foci were also observed in the lymph nodes on both sides of the neck, axillae, and mediastinum; in addition, there was evidence of bone destruction with hypermetabolic foci. Supplementary reports from the histological and immunohistochemical analyses of cervical lymph node tissue obtained during primary surgery confirmed the presence of metastatic PTC and poorly differentiated lung adenocarcinoma. In particular, one enlarged cervical lymph node located on the right side of the neck demonstrated tumor components of both PTC and lung adenocarcinoma. Pathological analysis of axillary lymph node puncture biopsy confirmed the presence of metastatic lung adenocarcinoma, and gene analysis revealed the presence of ALK fusion. The patient received targeted therapy based on a multidisciplinary discussion. However, she had a poor prognosis and died 2 years after the diagnosis. The initial thyroid ultrasound findings were reviewed retrospectively; the findings suggested that the possibility of double primary cancers should be considered in cases where the enlarged cervical lymph nodes are highly suspicious of PTC and present as inhomogeneous hypoechoic masses with irregular morphology.
引用
收藏
页数:7
相关论文
共 25 条
  • [21] INCIDENCE OF MULTIPLE PRIMARY CANCERS PER MAN-YEAR OF FOLLOW UP - 20-YEAR REVIEW FROM ELLIS FISCHEL STATE CANCER HOSPITAL
    SPRATT, JS
    HOAG, MG
    [J]. ANNALS OF SURGERY, 1966, 164 (05) : 775 - +
  • [22] Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study
    Tanjak, Pariyada
    Suktitipat, Bhoom
    Vorasan, Nutchavadee
    Juengwiwattanakitti, Panudeth
    Thiengtrong, Benjarat
    Songjang, Cholticha
    Therasakvichya, Suwanit
    Laiteerapong, Somsri
    Chinswangwatanakul, Vitoon
    [J]. BMC CANCER, 2021, 21 (01)
  • [23] Vasikova A, 2012, Klin Onkol, V25, P434
  • [24] Concomitant pulmonary and thyroid tumors identified by FDG PET/CT and immunohistochemical techniques
    Zhu, Guangwen
    Li, Hong
    Zhang, Yanjun
    Li, Yaming
    Liang, Shujun
    Liu, Jia
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2011, 9
  • [25] Meta-analysis of incidence and risk of severe adverse events and fatal adverse events with crizotinib monotherapy in patients with ALK-positive NSCLC
    Zhu, Qian
    Hu, Hao
    Jiang, Feng
    Guo, Chang Ying
    Yang, Xiong Wen
    Liu, Xi
    Kuang, Yu Kang
    [J]. ONCOTARGET, 2017, 8 (43) : 75372 - 75380